The strengths of blockchain technologies could help address the weaknesses of health care systems to store and secure medical records.
Disruptive science can have a significant impact outside of our own domains of research and into our personal lives. Keeping abreast of these developments can help prepare and inspire.
Genome research suggests that enteric fever, a potentially lethal disease more commonly found in hot countries, was present in medieval Europe.
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, new findings suggest.
The debate about the pros and cons of genetically screening embryos is deeply entrenched. Perhaps we should let couples decide?
Scientists have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought.
Natural selection shapes genomes to evolve and to adapt but, are the rules of natural selection also applying to cancer genome evolution? Researchers suggest negative selection acting on cancer-essential genes plays a more important role than previously anticipated.
A new method makes it possible to systematically identify specialised proteins that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.
Personalised medicine has been a goal of researchers and doctors for a long time. Now, researchers have developed what they call a personalised Therapeutic Intervention Fingerprint (pTIF), for patients with neurological disease.
Researchers at Harvard Medical School have found further evidence that supports the notion that viruses could help cause the onset of Alzheimer’s disease; an idea that was once ridiculed by other sceptics and researchers.
Scientists are taking advantage of the “self-homing” abilities of cancer cells and are creating armies of cancer-killing cells using CRISPR gene-editing.